ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Eliem Therapeutics Inc

Eliem Therapeutics Inc (ELYM)

8.81
0.12
(1.38%)
Closed June 15 4:00PM
8.81
0.00
(0.00%)
After Hours: 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
8.81
Bid
8.82
Ask
9.26
Volume
179,499
8.52 Day's Range 9.25
2.34 52 Week Range 11.55
Market Cap
Previous Close
8.69
Open
8.66
Last Trade
2
@
8.91
Last Trade Time
Financial Volume
$ 1,623,518
VWAP
9.0447
Average Volume (3m)
968,737
Shares Outstanding
27,572,664
Dividend Yield
-
PE Ratio
-6.92
Earnings Per Share (EPS)
-1.27
Revenue
-
Net Profit
-35.12M

About Eliem Therapeutics Inc

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Eliem Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELYM. The last closing price for Eliem Therapeutics was $8.69. Over the last year, Eliem Therapeutics shares have traded in a share price range of $ 2.34 to $ 11.55.

Eliem Therapeutics currently has 27,572,664 shares outstanding. The market capitalization of Eliem Therapeutics is $242.92 million. Eliem Therapeutics has a price to earnings ratio (PE ratio) of -6.92.

ELYM Latest News

Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm

Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm PR Newswire NEW YORK, April 11, 2024 NEW YORK, April 11, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.44.756242568378.419.497.93626748.56447822CS
40.759.305210918118.069.587.025970918.12907912CS
125.89201.7123287672.9211.552.529687375.21798987CS
266.18234.9809885932.6311.552.524535645.19568458CS
526213.5231316732.8111.552.342381165.07126552CS
156-7.44-45.784615384616.2529.692.211322156.95320178CS
260-7.44-45.784615384616.2529.692.211322156.95320178CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M